Latest Cutaneous lupus erythematosus Stories
John Galgiani, M.D. and Chaim Putterman, M.D.
-- CHABLIS-SC1 study passes futility analysis and will continue to completion with an enhanced endpoint HAYWARD, Calif., Feb.
Improving Lupus Research and Care among Budget Priorities NEW YORK, Dec.
Honors Visionary Healthcare Advocate, Arts Champion and Philanthropist Iris Cantor NEW YORK, Nov. 25, 2014 /PRNewswire/ -- The S.L.E.
2014 Distinguished Innovators Awards Recruit Immunology Leaders into Lupus Field to Find Root Causes that Can Propel New Treatments and a Cure NEW YORK, Oct.
A Substantial Need Remains for Emerging SLE Biologics That Can Prevent Acute Flares and That Treat Severe Manifestations, According to Findings from Decision Resources Group BURLINGTON, Mass.,
Hundreds Step Up For New Lupus Treatments NEW YORK, Sept.
A new study reveals that one in six patients with systemic lupus erythematosus (SLE) is readmitted to the hospital within 30 days of being discharged.
HERZLIYA, Israel, July 16, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd.
--Novel Biologic Targets Innovative New Mechanism in Lupus-- SEATTLE, July 16, 2014 /PRNewswire/ -- Resolve Therapeutics, LLC announced today the initiation of a multi-dose, one month
- Large; stout; burly.